A Study of Sunitinib In Young Patients With Advanced Gastrointestinal Stromal Tumor

NCT01396148 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

6

Enrollment

INDUSTRY

Sponsor class

Conditions

Gastrointestinal Stromal Tumors

Interventions

DRUG: sunitinib malate dose escalation
DRUG: sunitinib malate

Sponsor

Pfizer